These findings may predict that during the pathogenesis of IIM, the reduced expression of TRIM21 weakens the ubiquitination process of related regulatory factors (such as IRFs), leading to an imbalance between pro-inflammatory and anti-inflammatory cytokines, thereby triggering a persistent chronic inflammatory process. The gene discussed is TRIM21; the disease is acquired idiopathic inflammatory myopathy.